Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1983 Apr;42(2):151–154. doi: 10.1136/ard.42.2.151

Plasma prednisolone studies in rheumatic patients.

M Hayes, A F Alam, F E Bruckner, S M Doherty, A Myles, J English, V Marks, J Chakraborty
PMCID: PMC1001089  PMID: 6601933

Abstract

Prednisolone concentration in plasma after a daily maintenance steroid dose was monitored in 83 patients with rheumatic diseases. Although no restrictions were imposed on the intake of food or drink, plasma drug levels tended to peak at 1 h after the ingestion of the standard tablets, whereas intestinal absorption of the enteric-coated preparation was found to be most unpredictable. A profound individual variation was observed in plasma prednisolone concentrations, and neither total nor unbound drug levels showed any consistent relationship with the size of the prednisolone dose or the control of the disease activity. The basal cortisol production was suppressed in one-third of the patients. There is no support from this study for the concept of an 'optimum therapeutic range' of plasma prednisolone for the treatment of rheumatic disease.

Full text

PDF
151

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakran I., Jr, Korsić M., Duraković Z., Vrhovac B., Tajić M. The effect of alternate-day prednisone therapy on cortisol secretion rate in corticosteroid-dependent asthmatics. Int J Clin Pharmacol Biopharm. 1977 Feb;15(2):57–60. [PubMed] [Google Scholar]
  2. Chakraborty J., Hayes M., English J., Baylis M., Marks V. Prednisolone concentrations in plasma, saliva and urine. Eur J Clin Pharmacol. 1981 Jan;19(1):79–81. doi: 10.1007/BF00558389. [DOI] [PubMed] [Google Scholar]
  3. Elliott P. R., Powell-Tuck J., Gillespie P. E., Laidlow J. M., Lennard-Jones J. E., English J., Chakraborty J., Marks V. Prednisolone absorption in acute colitis. Gut. 1980 Jan;21(1):49–51. doi: 10.1136/gut.21.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. MATTINGLY D. A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol. 1962 Jul;15:374–379. doi: 10.1136/jcp.15.4.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Pickup M. E. Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet. 1979 Mar-Apr;4(2):111–128. doi: 10.2165/00003088-197904020-00004. [DOI] [PubMed] [Google Scholar]
  6. Scott N. R., Chakraborty J., Marks V. Determination of prednisolone, prednisone, and cortisol in human plasma by high-performance liquid chromatography. Anal Biochem. 1980 Nov 1;108(2):266–268. doi: 10.1016/0003-2697(80)90580-1. [DOI] [PubMed] [Google Scholar]
  7. Uribe M., Schalm S. W., Summerskill W. H., Go V. L. Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisone. Gastroenterology. 1976 Aug;71(2):362–364. [PubMed] [Google Scholar]
  8. Wilson C. G., Ssendagire R., May C. S., Paterson J. W. Measurement of plasma prednisolone in man. Br J Clin Pharmacol. 1975 Aug;2(4):321–325. doi: 10.1111/j.1365-2125.1975.tb02778.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES